FDA lifts partial hold on OncoMed's cancer drug trials

Reuters:  OncoMed Pharmaceuticals Inc said the U.S. Food and Drug Administration lifted a partial hold on patient enrolments for three trials testing its experimental cancer drug, vantictumab.

The drugmaker's stock rose as much 9 percent in early trade.

Read article